• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Methylprednisolone Versus Dexamethasone in COVID-19: A Meta-Analysis of Nonrandomized Studies.

作者信息

Beran Azizullah, Ayesh Hazem, Mhanna Mohammed, Srour Omar, Musallam Rami, Sayeh Wasef, Khokher Waleed, Altorok Nehaya, Noori Zaid, Assaly Ragheb, Altorok Nezam

机构信息

Department of Internal Medicine, University of Toledo, Toledo, OH.

Department of Internal Medicine, St. Vincent Charity Medical Center, Cleveland, OH.

出版信息

Am J Ther. 2022;29(3):e354-e357. doi: 10.1097/MJT.0000000000001506. Epub 2022 Apr 11.

DOI:10.1097/MJT.0000000000001506
PMID:35533326
Abstract
摘要

相似文献

1
Methylprednisolone Versus Dexamethasone in COVID-19: A Meta-Analysis of Nonrandomized Studies.甲基强的松龙与地塞米松治疗新冠肺炎的疗效比较：非随机研究的荟萃分析
Am J Ther. 2022;29(3):e354-e357. doi: 10.1097/MJT.0000000000001506. Epub 2022 Apr 11.
2
The effect of glucocorticoids on mortality in severe COVID-19 patients: Evidence from 13 studies involving 6612 cases.糖皮质激素对重症 COVID-19 患者死亡率的影响：来自涉及 6612 例患者的 13 项研究的证据。
Medicine (Baltimore). 2021 Oct 8;100(40):e27373. doi: 10.1097/MD.0000000000027373.
3
Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia.地塞米松与调整体重后的甲基泼尼松龙治疗中重度 SARS-CoV-2 肺炎患者的比较。
Med Clin (Barc). 2023 Feb 24;160(4):156-159. doi: 10.1016/j.medcli.2022.06.015. Epub 2022 Jul 20.
4
Treatment with 3-day methylprednisolone pulses in severe cases of COVID-19 compared with the standard regimen protocol of dexamethasone.与地塞米松标准治疗方案相比，在 COVID-19 重症患者中使用 3 天甲泼尼龙脉冲治疗。
J Investig Med. 2022 Aug;70(6):1423-1428. doi: 10.1136/jim-2021-002274. Epub 2022 Apr 4.
5
Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.COVID-19 肺炎的糖皮质激素（CORTIVID）治疗：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):43. doi: 10.1186/s13063-020-04999-4.
6
Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: a randomized clinical trial.静脉注射地塞米松和甲泼尼龙治疗 COVID-19 住院患者的效果比较：一项随机临床试验。
Int J Infect Dis. 2022 Sep;122:659-664. doi: 10.1016/j.ijid.2022.07.019. Epub 2022 Jul 9.
7
A Comparison of the Efficacy of Adjuvant Parenteral Methylprednisolone and Dexamethasone in Reducing Covid-19 Disease Severity and Mortality among the Moderate to Critical Patients -A Retrospective Study.辅助性肌内注射甲泼尼龙和地塞米松治疗中重度至危重症 COVID-19 患者的疗效比较：一项回顾性研究。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
8
Is dexamethasone an effective treatment for severe COVID-19 patients: Journal Club review.地塞米松对重症 COVID-19 患者是否为有效治疗方法：期刊俱乐部综述。
CJEM. 2021 Mar;23(2):159-161. doi: 10.1007/s43678-020-00033-3. Epub 2021 Jan 4.
9
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.联合使用甲基强的松龙和瑞德西韦对 SARS-CoV-2 感染仓鼠模型的有益作用。
Emerg Microbes Infect. 2021 Dec;10(1):291-304. doi: 10.1080/22221751.2021.1885998.
10
A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19.COVID-19 重症监护患者中甲基强的松龙与地塞米松的比较。
J Intensive Care Med. 2021 Jun;36(6):673-680. doi: 10.1177/0885066621994057. Epub 2021 Feb 25.

引用本文的文献

1
Efficacy and safety of glucocorticoids use in patients with COVID-19: a systematic review and network meta‑analysis.糖皮质激素治疗 COVID-19 患者的疗效和安全性：系统评价和网络荟萃分析。
BMC Infect Dis. 2023 Dec 20;23(1):896. doi: 10.1186/s12879-023-08874-w.
2
Methylprednisolone or dexamethasone? How should we choose to respond to COVID-19?: A systematic review and meta-analysis of randomized controlled trials.甲泼尼龙还是地塞米松？我们应该如何选择应对 COVID-19？：一项随机对照试验的系统评价和荟萃分析。
Medicine (Baltimore). 2023 Sep 8;102(36):e34738. doi: 10.1097/MD.0000000000034738.
3
A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone.
糖皮质激素治疗重症 COVID-19 的系统评价和荟萃分析：甲泼尼龙与地塞米松。
BMC Infect Dis. 2023 May 5;23(1):290. doi: 10.1186/s12879-023-08280-2.
4
Renaissance of glucocorticoids in critical care in the era of COVID-19: ten urging questions.COVID-19 时代重症监护中糖皮质激素的复兴：十个紧迫问题。
Crit Care. 2022 Oct 8;26(1):308. doi: 10.1186/s13054-022-04185-9.